词条 | Lenograstim |
释义 |
| Verifiedfields = changed | verifiedrevid = 447995983 | IUPAC_name = | image = | tradename = Euprotin, Granocyte, Lenobio, Neutrogin | Drugs.com = {{drugs.com|international|lenograstim}} | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = none | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 135968-09-1 | ATC_prefix = L03 | ATC_suffix = AA10 | PubChem = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 6WS4C399GB | chemical_formula = | molecular_weight = }} Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator.[1][2] It is developed by Chugai Pharmaceuticals under the brand name Granocyte. References1. ^{{cite journal | title = USAN Council. List No. 340. New names. Lenograstim | journal = Clin. Pharmacol. Ther. | volume = 52 | issue = 1 | pages = 112–113 |date=July 1992 | pmid = 1284891 | doi = 10.1038/clpt.1992.117 }} {{Immunostimulants}}{{Cytokine receptor modulators}}{{Growth factor receptor modulators}}{{antineoplastic-drug-stub}}2. ^{{cite journal |vauthors=Amadori S, Suciu S, Jehn U, Stasi R, Thomas X, Marie JP, Muus P, Lefrère F, Berneman Z, Fillet G, Denzlinger C, Willemze R, Leoni P, Leone G, Casini M, Ricciuti F, Vignetti M, Beeldens F, Mandelli F, De Witte T | title = Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study | journal = Blood | volume = 106 | issue = 1 | pages = 27–34 |date=July 2005 | pmid = 15761020 | pmc = 1895135 | doi = 10.1182/blood-2004-09-3728 }} 1 : Immunostimulants |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。